Publications by authors named "Maryrose Conklyn"

Claim this Profile
T
The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia.
Elizabeth Kudlacz, Maryrose Conklyn, Catharine Andresen, Carrie Whitney-Pickett, Paul Changelian

Eur J Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and validation of a flow cytometric method for immunophenotyping peripheral blood lymphocytes from cynomolgus monkeys (Macaca fascicularis).
Deanna L Baker, Deborah L Finco-Kent, William J Reagan, Maryrose J Conklyn, Thomas T Kawabata

Vet Clin Pathol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing.
Maryrose Conklyn, Catharine Andresen, Paul Changelian, Elizabeth Kudlacz

J Leukoc Biol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent small molecule CCR1 antagonists.
John C Kath, William H Brissette, Matthew F Brown, Maryrose Conklyn, Amy P DiRico

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel CCR1 antagonists with improved metabolic stability.
Matthew F Brown, Mike Avery, William H Brissette, J H Chang, Kevin Colizza, Maryrose Conklyn

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models.
Elizabeth Kudlacz, Bret Perry, Perry Sawyer, Maryrose Conklyn, Sandra McCurdy

Am J Transplant· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.
Ronald P Gladue, Laurie A Tylaska, William H Brissette, Paul D Lira, John C Kath, Maryrose J Conklyn

J Biol Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.
Paul S Changelian, Mark E Flanagan, Douglas J Ball, Craig R Kent, Kelly S Magnuson, Maryrose J Conklyn

Science· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional effects of eotaxin are selectively upregulated on IL-5 transgenic mouse eosinophils.
Elizabeth Kudlacz, Carrie Whitney, Catharine Andresenl, Maryrose Conklyn

Inflammation· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis